药剂师避免或减少重症和紧急病患儿科的医疗费用:PHARM-PEDS研究
Amy L Kiskaddon1,2, Michelle M Smith3, Frankie Gilliland3
1Department of Pharmacy, Johns Hopkins All Children's Hospital, St. Petersburg, FL.
儿科重症监护药剂师通过接受的干预措施显著降低医疗保健成本,潜在的成本回避 (CA) 比率在1.5:1至5.2:1之间. 他们的工作表明,在管理重症儿科患者方面,他们获得了巨大的经济利益.
科学领域:
- 药理学 药理学是指药理学的学科.
- 医疗保健管理的管理
- 儿科重症监护 儿科重症监护
背景情况:
- 儿科重症监护室 (PCCU) 是复杂的环境,需要专门的药物专业知识.
- 临床药剂师在优化患者护理和PCCU资源利用方面的作用越来越被认可.
- 量化儿科重症监护药剂师产生的成本回避 (CA) 对于证明其价值至关重要.
研究的目的:
- 为了分类由儿科重症监护临床药剂师进行的干预.
- 量化被接受的药剂师干预产生的成本回避 (CA).
- 评估儿科重症监护药剂师对医疗保健成本的财务影响.
主要方法:
- 在美国的学术和社区医院进行了一项多中心,前性,观察性研究.
- 儿科临床药剂师记录了112个班次接受的干预措施.
- 干预措施被分为38个类别,并计算了相关的成本回避.
主要成果:
- 19名药剂师记录了861名重症儿科患者的1458次接受干预,导致450,590美元的CA.
- 患者护理的个性化占CA (217,949美元) 的最大部分.
- 平均CA为每次干预309美元,每天患者523美元,每次药剂师轮班4023.13美元.
结论:
- 儿科重症监护药剂师可以显著避免医疗保健成本.
- 药剂师参与重症儿科患者护理,可以带来巨大的经济利益.
- 潜在的货币成本避免与药剂师工资比率在1.5:1至5.2:1之间.
更多相关视频
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
相关概念视频
Factors Affecting Drug Response: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
